Analyst Ratings for Inhibrx Biosciences (INBX)
INBX Rating Summary
INBX Price Target Summary
- Highest: $325.00 (Stifel)
- Lowest: $200.00 (LifeSci Capital)
- Average: $256.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$256.67 (+111.4%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
Avg. $ Target:
$256.67 (+111.4%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/24/2026 | H.C. Wainwright | Robert Burns | New Coverage | Buy (N/A) |
245.00 (N/A) |
103.63 (121.43) |
17.18% | Details |
| 4/24/2026 | LifeSci Capital | N/A | New Coverage | Outperform (N/A) |
200.00 (N/A) |
119.93 (121.43) |
1.25% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
